Investment in MedTech company eLive

eLive Ecosystem Oy is a Savonlinna-based health and medical technology growth company founded in 2016, specializing in non-contact vital signs measurement and application. The eLive product family includes a medical device launched in 2023, research systems, and market-leading OEM solutions for sleep and sitting measurement. 

With eLive’s devices, vital sign measurement and monitoring can be done easily and discreetly at home. The company’s patented sensor and analysis technology for non-contact measurement of vital signs is unobtrusive but is very good in terms of measurement accuracy. 

The startup is developing a stand-alone medical device suitable for sleep apnea verification and therapy monitoring in healthcare technology. In high-income countries, symptomatic sleep apnea is estimated to be as high as 17%, and sleep apnea is also an under-diagnosed condition. The medical device is suitable for verifying the form of sleep apnea that can be treated with medication, and the device is already ready for clinical validation.

Redstone’s partner Oskari Lehtonen explains the rationale of the deal as follows: “When we started to analyze this investment possibility, we were surprised at the magnitude of sleep apnea problem in the western world. We see eLive as a great company that could provide relief for the patients that are suffering the condition.”

eLive Ecosystem Oy is among the first companies financed by Redsotnes South Savo Growth Fund. The fund invests in seed and growth-stage young companies that aim for solid growth and internationalization and have a connection to Etelä-Savo. The fund is a joint project of private investors, Redstone Nordics Oy, the region’s cities, and the ELY Center to accelerate the development of growth companies.

Welcome to the Redstone family!